Strong cash position and cash generation
Ended Q1 with approximately $911 million in cash and investments and generated $109 million of operating cash flow in the quarter, supporting balance sheet flexibility.
Disciplined capital return to shareholders
Returned more than $187 million to shareholders over the last 12 months through dividends and share repurchases; completed a $100M repurchase authorization (≈924,000 shares) and repurchased ≈633,000 shares for $66M in Q1; Board authorized a new $400 million share repurchase program and declared a $0.50 per share cash dividend for Q2.
Material gross margin remains high
Total gross margin was 75% in Q1 2026 (within the company's full-year guidance range of 74%–76%), down slightly from 77% in Q1 2025 but still indicative of a high-margin business model.
Ongoing R&D and technology leadership
Increasing application of AI/ML to accelerate materials discovery (e.g., predicting thermal processing stability up to 10,000× faster than traditional DFT with near-comparable accuracy); continued focus on phosphorescent blue and next-generation emitters (red, green, yellow).
Phosphorescent blue commercial opportunity
Company reiterates conviction in phosphorescent blue commercialization, estimating up to an initial 25% improvement in OLED panel energy efficiency when adopted; invited technical presentation at SID Display Week to share additional details.
Customer partnerships and milestones
Announced new long-term agreements with Tianma and LG Display; highlighted incorporation of the company's phosphorescent material into Visionox's first commercial green PSF product targeting BT2020 — a notable industry milestone for next-generation architectures.
Industry capacity expansion supports long-term growth
Reports of multi-year Gen 8.6 capacity investments (Samsung Display $3.1B nearing shipments; BOE $9B targeting H2 mass production; Visionox and TCL China Star investments) support expectation of an expanding OLED market and longer-term demand ramp.
Measured guidance and operating discipline
Revised FY revenue guidance to $630M–$670M while expecting Q2 to be sequentially higher than Q1 and the second half to be stronger than the first; OpEx trending toward mid single-digit growth with continued caution on spending while prioritizing R&D.